FCCC LOGO Faculty Publications
Madnick D , Handorf E , Ortiz A , Sorice K , Nagappan L , Moccia M , Cheema K , Vijayvergia N , Dotan E , Lynch SM
Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients
J Gastrointest Oncol. 2020 Aug;11(4) :633-643
PMID: 32953147    PMCID: PMC7475328   
Back to previous list
Abstract
BACKGROUND: Pancreatic adenocarcinoma (PCA) incidence is higher in Black compared to White patients. Beyond race, neighborhood socioeconomic status (nSES) may also inform disparities. However, these effects on metastatic pancreatic adenocarcinoma (mPCA) are not well-studied. The aim of this study was to explore whether nSES influences survival in patients with mPCA. METHODS: nSES measures were derived from U.S. census data at the census tract (CT) level. We correlated medical records of mPCA patients (diagnosed 2010-2016; n=370) to nSES measures retrospectively via a geocode derived from patient address. Multivariable cox proportional hazards models were used to identify patient-level (age, sex, race, marital status, treatment (radiation/chemo/surgery), PCA family history, stage, Jewish ancestry, tobacco use, BMI, diabetes, and statin use) and nSES measures (deprivation, racial concentration, stability, transportation access, immigration) associated with mPCA survival; P values <0.05 were significant. RESULTS: Eighty-two percent of patients were White; less than one-third of patients resided in highly deprived neighborhoods. Three hundred thirty-three mPCA patient deaths occurred, with a survival ranging from 7-9 months (median 8 months). Patient-level factors including younger age, receipt of chemotherapy or initial surgery and statin use, were associated with improved survival, whereas neighborhood stability (i.e., a higher % of residents still living in the same house as 1 year ago) was significantly associated with poor pancreatic survival. CONCLUSIONS: Our findings suggest nSES has limited effect on survival of mPCA patients as compared to clinical variables. This may be due to the aggressive nature of this cancer, however, additional studies with larger, more diverse cohorts are needed to better understand the effect of nSES on survival of patients with mPCA.
Notes
2219-679x Madnick, David Handorf, Elizabeth Ortiz, Angel Sorice, Kristen Nagappan, Lavanya Moccia, Matthew Cheema, Khadija Vijayvergia, Namrata Dotan, Efrat Lynch, Shannon M P30 CA006927/CA/NCI NIH HHS/United States Journal Article J Gastrointest Oncol. 2020 Aug;11(4):633-643. doi: 10.21037/jgo-20-39.